When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153
0 Bekeken
• 07/10/23
0
0
insluiten
administrator
abonnees
Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties